Patents by Inventor Jonathan B. Grimm

Jonathan B. Grimm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12552938
    Abstract: The present invention is generally directed to the synthesis and use of fluorophores. It is more specifically directed to the synthesis and use of deuterated fluorophores. In one case, the present invention provides a compound of the structure shown in FIG. 44.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: February 17, 2026
    Assignee: Howard Hughes Medical Institute
    Inventors: Luke Lavis, Jonathan B. Grimm
  • Publication number: 20260015335
    Abstract: A compound of the following structure is provided:
    Type: Application
    Filed: August 27, 2025
    Publication date: January 15, 2026
    Inventors: Luke D. Lavis, Jonathan B. Grimm
  • Publication number: 20260001857
    Abstract: A compound of the following structure is provided:
    Type: Application
    Filed: September 5, 2025
    Publication date: January 1, 2026
    Inventors: Luke D. Lavis, Jonathan B. Grimm
  • Publication number: 20250282744
    Abstract: A compound of the following structure is provided:
    Type: Application
    Filed: May 23, 2025
    Publication date: September 11, 2025
    Inventors: Luke D. Lavis, Jonathan B. Grimm
  • Patent number: 12344594
    Abstract: A compound of the following structure is provided:
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: July 1, 2025
    Assignee: HOWARD HUGHES MEDICAL INSTITUTE
    Inventors: Luke D. Lavis, Jonathan B. Grimm
  • Publication number: 20250115628
    Abstract: Fluorescent compounds are provided, including polycyclic chemical fluorophores, as well as method for making and using such compounds.
    Type: Application
    Filed: September 23, 2024
    Publication date: April 10, 2025
    Inventors: Luke D. Lavis, Jonathan B. Grimm
  • Publication number: 20240239818
    Abstract: The application discloses a compound having a moiety that is either an affinity tag-containing moiety or a protein-manipulation moiety, a self-labeling protein (SLP) ligand, and a rhodamine dye linking the affinity tag-containing moiety or a protein-manipulation moiety to the SLP ligand. Also disclosed is a complex, which includes the compound and a SLP. Also disclosed is a method that involves contacting the compound and a SLP with a cell, and visualizing fluorescence in the cell or purifying the SLP and associated biological components from the cell.
    Type: Application
    Filed: December 20, 2023
    Publication date: July 18, 2024
    Inventors: Luke D. LAVIS, Pratik Kumar, Carla Nicolini, Jonathan B. Grimm
  • Patent number: 11958976
    Abstract: Provided are a photoactive fluorophore, a photoactive ligand, and a photoactive complex. The photoactive fluorophore includes a photoactivatable derivative of an azetidine-containing Janelia-Fluor dye. The photoactive ligand includes a photoactive fluorophore and a protein tag. The photoactive complex includes a photoactive ligand conjugated to a protein. Also provided are methods of in vivo labeling with and photoactivation of the photoactive fluorophore, ligand, and complex.
    Type: Grant
    Filed: October 27, 2022
    Date of Patent: April 16, 2024
    Assignee: HOWARD HUGHES MEDICAL INSTITUTE
    Inventors: Luke D. Lavis, Jonathan B. Grimm
  • Publication number: 20240052169
    Abstract: The present invention is generally directed to the synthesis and use of fluorophores. It is more specifically directed to the synthesis and use of deuterated fluorophores. In one case, the present invention provides a compound of the structure shown in FIG. 44.
    Type: Application
    Filed: September 11, 2023
    Publication date: February 15, 2024
    Applicant: Howard Hughes Medical Institute
    Inventors: Luke Lavis, Jonathan B. Grimm
  • Patent number: 11787946
    Abstract: The present invention is generally directed to the synthesis and use of fluorophores. It is more specifically directed to the synthesis and use of deuterated fluorophores. In one case, the present invention provides a compound of the structure shown in FIG. 44.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: October 17, 2023
    Assignee: Howard Hughes Medical Institute
    Inventors: Luke Lavis, Jonathan B. Grimm
  • Publication number: 20230095090
    Abstract: Provided are a photoactive fluorophore, a photoactive ligand, and a photoactive complex. The photoactive fluorophore includes a photoactivatable derivative of an azetidine-containing Janelia-Fluor dye. The photoactive ligand includes a photoactive fluorophore and a protein tag. The photoactive complex includes a photoactive ligand conjugated to a protein. Also provided are methods of in vivo labeling with and photoactivation of the photoactive fluorophore, ligand, and complex.
    Type: Application
    Filed: October 27, 2022
    Publication date: March 30, 2023
    Inventors: Luke D. Lavis, Jonathan B. Grimm
  • Publication number: 20210347994
    Abstract: The present invention is generally directed to the synthesis and use of fluorophores. It is more specifically directed to the synthesis and use of deuterated fluorophores. In one case, the present invention provides a compound of the structure shown in FIG. 44.
    Type: Application
    Filed: July 6, 2021
    Publication date: November 11, 2021
    Applicant: HOWARD HUGHES MEDICAL INSTITUTE
    Inventors: Luke LAVIS, Jonathan B. Grimm
  • Patent number: 11091643
    Abstract: The present invention is generally directed to the synthesis and use of fluorophores. It is more specifically directed to the synthesis and use of deuterated fluorophores. In one case, the present invention provides a compound of the structure shown in FIG. 44.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: August 17, 2021
    Assignee: Howard Hughes Medical Institute
    Inventors: Luke Lavis, Jonathan B. Grimm
  • Publication number: 20210171490
    Abstract: A compound of the following structure is provided:
    Type: Application
    Filed: December 9, 2020
    Publication date: June 10, 2021
    Inventors: Luke D. LAVIS, Jonathan B. GRIMM
  • Publication number: 20190367736
    Abstract: The present invention is generally directed to the synthesis and use of fluorophores. It is more specifically directed to the synthesis and use of deuterated fluorophores. In one case, the present invention provides a compound of the structure shown in FIG. 44.
    Type: Application
    Filed: May 28, 2019
    Publication date: December 5, 2019
    Inventors: Luke Lavis, Jonathan B. Grimm
  • Patent number: 10495632
    Abstract: The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: December 3, 2019
    Assignee: HOWARD HUGHES MEDICAL INSTITUTE
    Inventors: Luke D. Lavis, Jonathan B. Grimm, Jiji Chen, Timothee Lionnet, Zhengjian Zhang, Andrey Revyakin, Joel Slaughter
  • Patent number: 10407399
    Abstract: The presently-disclosed subject matter relates to analyte-activated photolabile compounds. The compounds include the formula: wherein Z includes a maskable molecule; L is selected from a bond, C, C(O), O, alkyl, (O)alkyl, and alkoxy; R1 is selected from H, halogen, alkyl, and acyl; each R2 is independently selected from H, alkyl, aryl, and acyl, and is optionally substituted with one or more heteroatoms independently selected from COOH and COO(alkyl); and R3 is selected from H, alkyl, aryl, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, CHO, COOH, COO(alkyl), COO(aryl), PO3H2, and SO3H, and is optionally substituted with one or more heteroatoms independently selected from N, O, and S, halogen, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO2, CHO, COO, COOH, COO(alkyl), COO(aryl), C(O)NR2, PO3H2, and/or SO3H. Also provided are methods of detecting calcium and treating a subject with the analyte-activated photolabile compounds.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: September 10, 2019
    Assignee: HOWARD HUGHES MEDICAL INSTITUTE
    Inventors: Luke D. Lavis, Jonathan B. Grimm, Laurel M. Heckman, Eric R. Schreiter
  • Publication number: 20190107534
    Abstract: The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.
    Type: Application
    Filed: December 6, 2018
    Publication date: April 11, 2019
    Inventors: Luke D. LAVIS, Jonathan B. GRIMM, Jiji CHEN, Timothee LIONNET, Zhengjian ZHANG, Andrey REVYAKIN, Joel SLAUGHTER
  • Publication number: 20190106573
    Abstract: Provided are a photoactive fluorophore, a photoactive ligand, and a photoactive complex. The photoactive fluorophore includes a photoactivatable derivative of an azetidine-containing Janelia-Fluor dye. The photoactive ligand includes a photoactive fluorophore and a protein tag. The photoactive complex includes a photoactive ligand conjugated to a protein. Also provided are methods of in vivo labeling with and photoactivation of the photoactive fluorophore, ligand, and complex.
    Type: Application
    Filed: May 22, 2017
    Publication date: April 11, 2019
    Inventors: Luke D. LAVIS, Jonathan B. GRIMM
  • Patent number: 10161932
    Abstract: The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: December 25, 2018
    Assignee: HOWARD HUGHES MEDICAL INSTITUTE
    Inventors: Luke D. Lavis, Jonathan B. Grimm, Jiji Chen, Timothee Lionnet, Zhengjian Zhang, Andrey Revyakin, Joel Slaughter